Users of GLP-1 receptor agonists had as much as fourfold higher likelihood for nail disorders, particularly onycholysis, compared with patients not taking the drugs, a large prospective study showed. #EADVCongress
https://www.medpagetoday.com/meetingcoverage/eadv/123238
@medpagetoday.com
@kernelmedstarry.bsky.social